Zobrazeno 1 - 10
of 209
pro vyhledávání: '"A. F. Ochsenbein"'
Autor:
S. S. Höpner, Ana Raykova, R. Radpour, M. A. Amrein, D. Koller, G. M. Baerlocher, C. Riether, A. F. Ochsenbein
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
Regulation of self-renewal is critical during steady state and stress in haematpoietic stem cells (HSCs), and underlies leukaemia pathology. Here, the authors show that LIGHT and its receptor LTβR promote quiescence and self-renewal of HSCs and that
Externí odkaz:
https://doaj.org/article/8bf20fdc21164bb0a145089a5033e21d
Autor:
Roberta Esposito, Andrés Lanzós, Tina Uroda, Sunandini Ramnarayanan, Isabel Büchi, Taisia Polidori, Hugo Guillen-Ramirez, Ante Mihaljevic, Bernard Mefi Merlin, Lia Mela, Eugenio Zoni, Lusine Hovhannisyan, Finn McCluggage, Matúš Medo, Giulia Basile, Dominik F. Meise, Sandra Zwyssig, Corina Wenger, Kyriakos Schwarz, Adrienne Vancura, Núria Bosch-Guiteras, Álvaro Andrades, Ai Ming Tham, Michaela Roemmele, Pedro P. Medina, Adrian F. Ochsenbein, Carsten Riether, Marianna Kruithof-de Julio, Yitzhak Zimmer, Michaela Medová, Deborah Stroka, Archa Fox, Rory Johnson
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-21 (2023)
Abstract Long noncoding RNAs (lncRNAs) are linked to cancer via pathogenic changes in their expression levels. Yet, it remains unclear whether lncRNAs can also impact tumour cell fitness via function-altering somatic “driver” mutations. To search
Externí odkaz:
https://doaj.org/article/ac68b1f51d77424ab680971f8fdf0575
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of clonal plasma cells in the bone marrow (BM). It is known that early genetic mutations in post-germinal center B/plasma cells are the cause of myelomagenesis. The
Externí odkaz:
https://doaj.org/article/0a95875e38f343f3931a95198121c0f3
Autor:
Haitang Yang, Yanyun Gao, Duo Xu, Ke Xu, Shun-Qing Liang, Zhang Yang, Amina Scherz, Sean R. R. Hall, Stefan Forster, Sabina Berezowska, Feng Yao, Adrian F. Ochsenbein, Thomas M. Marti, Gregor J. Kocher, Ralph A. Schmid, Patrick Dorn, Ren-Wang Peng
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-15 (2023)
Abstract Malignant pleural mesothelioma (MPM) is a lethal malignancy etiologically caused by asbestos exposure, for which there are few effective treatment options. Although asbestos carcinogenesis is associated with reactive oxygen species (ROS), th
Externí odkaz:
https://doaj.org/article/5254c7ce468140869bc77e5e71f90aa3
Autor:
Roberta Esposito, Andrés Lanzós, Tina Uroda, Sunandini Ramnarayanan, Isabel Büchi, Taisia Polidori, Hugo Guillen-Ramirez, Ante Mihaljevic, Bernard Mefi Merlin, Lia Mela, Eugenio Zoni, Lusine Hovhannisyan, Finn McCluggage, Matúš Medo, Giulia Basile, Dominik F. Meise, Sandra Zwyssig, Corina Wenger, Kyriakos Schwarz, Adrienne Vancura, Núria Bosch-Guiteras, Álvaro Andrades, Ai Ming Tham, Michaela Roemmele, Pedro P. Medina, Adrian F. Ochsenbein, Carsten Riether, Marianna Kruithof-de Julio, Yitzhak Zimmer, Michaela Medová, Deborah Stroka, Archa Fox, Rory Johnson
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/4e6d43c141ad486fbe88bece10724bab
Autor:
Thomas Pabst, Norbert Vey, Lionel Adès, Ulrike Bacher, Mario Bargetzi, Samson Fung, Gianluca Gaidano, Domenica Gandini, Anna Hultberg, Amy Johnson, Xuewen Ma, Rouven Müller, Kerri Nottage, Cristina Papayannidis, Christian Recher, Carsten Riether, Priya Shah, Jeffrey Tryon, Liang Xiu, Adrian F. Ochsenbein
Publikováno v:
Haematologica, Vol 108, Iss 7 (2023)
Cusatuzumab is a high-affinity, anti-CD70 monoclonal antibody under investigation in acute myeloid leukemia (AML). This two-part, open-label, multicenter, phase I/II trial evaluated cusatuzumab plus azacitidine in patients with newly diagnosed AML in
Externí odkaz:
https://doaj.org/article/44a72b022e1b4366bad1fca7a93513e4
Autor:
Adrian F. Ochsenbein, Carsten Riether, Ramin Radpour, Anne-Laure Huguenin, Elias D. Bührer, Michael A. Amrein, Mohamad F. Al Sayed
Hematopoiesis in patients with cancer is characterized by reduced production of red blood cells and an increase in myelopoiesis, which contributes to the immunosuppressive environment in cancer. Some tumors produce growth factors that directly stimul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f3bee810456bca8f6014ab1a36adff
https://doi.org/10.1158/0008-5472.c.6510785.v1
https://doi.org/10.1158/0008-5472.c.6510785.v1
Autor:
Adrian F. Ochsenbein, Carsten Riether, Ramin Radpour, Anne-Laure Huguenin, Elias D. Bührer, Michael A. Amrein, Mohamad F. Al Sayed
Table S1: suppl. cell cycle analysis to Fig 3; Table S2: suppl. BrDU and AnnexinV analysis to Fig 3; Table S3: suppl. analysis of the compositions of HSPC compartments to Fig 4; Figure S1: suppl. to Fig 1; Figure S2: suppl. to Fig 4; Figure S3: suppl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7986e1bd4d17aaee92211fc8dde92ee9
https://doi.org/10.1158/0008-5472.22420922.v1
https://doi.org/10.1158/0008-5472.22420922.v1
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
The effect of cancer immunotherapy on the endogenous immune response against tumors is largely unknown. Therefore, we studied immune responses against murine tumors expressing the glycoprotein (GP) and/or nucleoprotein of lymphocytic choriomeningitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d59691124c9ed8697ae6aca516bf77d
https://doi.org/10.1158/0008-5472.c.6495833
https://doi.org/10.1158/0008-5472.c.6495833
Autor:
Adrian F. Ochsenbein, Dorothee von Laer, Tsanan Giroglou, Bruno Eschli, Sabine Mumprecht, Daniel D. Pinschewer, Viktor Pavelic, Matthias Matter
Supplementary Legends 1-2 from Decreased Tumor Surveillance after Adoptive T-Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a8b4e399b6cb8090b39c41058bfd60
https://doi.org/10.1158/0008-5472.22368146.v1
https://doi.org/10.1158/0008-5472.22368146.v1